8-K/A: American Healthcare REIT Details Interim CEO Compensation

American Healthcare REIT, Inc. filed an amendment to disclose the compensation package for its Interim Chief Executive Officer and President, Jeffrey T. Hanson.

Summary

• Jeffrey T. Hanson has been appointed Interim Chief Executive Officer and President, effective February 3, 2026, while Danny Prosky, the current CEO, is on a leave of absence.
• Hanson will receive a base salary of $70,666.67 per month.
• He is eligible for a 2026 annual cash performance bonus with a target opportunity of 120% of his annualized base salary, pro-rated for his service period, based 70% on corporate performance and 30% on individual performance.
• By March 31, 2026, he will be granted two restricted stock unit (RSU) awards, each with a grant date value of no less than $2,027,075.
• One RSU award is time-based, vesting on the earlier of March 15, 2027, or within 30 days following the expiration of his term.
• The second RSU award is performance-based, subject to corporate performance goals consistent with other named executive officers.
• Both RSU awards are subject to pro-rata adjustment if his service as Interim CEO ends prior to December 31, 2026.
• Hanson will continue to serve as Chairman of the Board but will not receive additional compensation for Board service during his Interim CEO term, though prior equity awards will continue to vest.
• He is eligible for standard employee benefits but is not eligible for the American Healthcare Opps Holdings, LLC Executive Severance and Change in Control Plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-slightly positive development, as it formalizes compensation for an experienced interim leader, providing clarity during a period of CEO leave. The substantial compensation package, however, warrants scrutiny.

Positives

• Secures experienced leadership with Jeffrey T. Hanson, a former CEO (2015-2021) and current Chairman, ensuring continuity during the CEO's leave of absence.
• The compensation structure includes performance-based incentives (annual bonus and performance-based restricted stock units), aligning executive interests with company performance.
• The interim role provides stability and experienced guidance during a period of leadership transition.

Negatives

• The substantial compensation package for an interim role, including over $4 million in equity awards, could be viewed as significant for a temporary position.
• The leave of absence of the permanent CEO, Danny Prosky, introduces an element of uncertainty regarding long-term leadership stability.

Risks

• Uncertainty regarding the duration of Danny Prosky's leave of absence and the eventual return or permanent replacement of the CEO.
• Potential for disruption if Mr. Hanson's interim service ends prior to December 31, 2026, which would result in pro-rated equity awards and necessitate another leadership transition.
• The 'at-will' employment nature for the Interim CEO means the company or Mr. Hanson can terminate the arrangement at any time, potentially leading to further leadership changes.

Future Outlook

The filing primarily details compensation for an interim role and does not provide explicit forward-looking statements regarding company performance or strategic direction beyond the duration of the interim CEO's tenure and the vesting schedules of his equity awards. The company aims for leadership continuity during the current CEO's leave.

Management Comments

• "This Agreement forms the complete and exclusive statement of your employment agreement with the Company. It supersedes any other agreements or promises made to you by anyone whether oral or written."

Industry Context

StockSavvy.ai notes that the healthcare REIT sector, like many real estate investment trusts, faces ongoing challenges related to interest rate fluctuations, healthcare policy changes, and demographic shifts impacting demand for various healthcare properties. The appointment of an interim CEO, even a former one, during a leave of absence for the current CEO, suggests a focus on maintaining stability and experienced leadership in a potentially volatile market. This move aims to reassure investors of steady hands at the helm during a period of transition, which is crucial for REITs that rely on consistent operational performance and investor confidence.

Comparison to Industry Standards

• The compensation package for an interim CEO, including a monthly base salary of $70,666.67 and over $4 million in equity awards, appears robust. For comparison, interim CEO compensation in the REIT sector can vary widely based on company size and market conditions. Some larger REITs might offer higher base salaries but potentially less immediate equity, while smaller REITs might offer lower overall packages.
• The structure, with a mix of base salary, performance-based cash bonus (120% target), and both time-based and performance-based restricted stock units, is a standard approach to executive compensation, aligning incentives with both tenure and company performance.
• The exclusion from the Executive Severance and Change in Control Plan for an interim executive is a common practice, as interim roles are by nature temporary and typically do not carry the same long-term severance commitments as permanent executive positions.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Provides clarity on executive leadership and associated costs during a CEO's leave, potentially stabilizing investor confidence. The substantial compensation package could be a point of discussion.
• Employees: Ensures leadership continuity, which can provide stability during a period of executive transition.
• Management: Defines the terms of service and compensation for the Interim CEO, and clarifies the status of the CEO on leave.

Next Steps

• Granting of time-based and performance-based restricted stock units on or before March 31, 2026.
• Determination and payment of the 2026 annual cash performance bonus on or before March 15, 2027.
• Vesting of time-based restricted stock units by March 15, 2027, or within 30 days following the expiration of the Interim CEO's term.
• The Board will eventually determine the end date of Mr. Hanson's interim CEO service.

Key Dates

Recommendation

The filing primarily details the compensation for an interim CEO, a necessary step following the announcement of the permanent CEO's leave of absence. While the compensation package is substantial, it formalizes an expected arrangement and provides clarity on leadership during a transitional period. It does not introduce new operational or financial performance data that would warrant a change in investment thesis. Investors should hold, awaiting further updates on the permanent CEO's status and the company's broader strategic direction.

Keywords

American Healthcare REIT, AHR, Interim CEO, Executive Compensation, Restricted Stock Units, Performance Stock Units, Corporate Governance, Leadership Change, SEC Filing, 8-K/A, Healthcare REIT